Adaptive Biotechnologies (ADPT) Change in Acquisitions & Divestments (2018 - 2026)

Adaptive Biotechnologies has reported Change in Acquisitions & Divestments for 9 years, with the latest figure at $48.8 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 37.02% year-over-year to $48.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $193.9 million (down 36.14% YoY) and the FY2025 annual result came in at $222.6 million, down 31.65% from the prior year.
• Change in Acquisitions & Divestments rose to $48.8 million in Q1 2026 per ADPT's latest filing, from $39.1 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $155.0 million in Q1 2023 and troughed at $35.0 million in Q2 2022.
• A 5-year average of $86.2 million and a median of $77.5 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments sank 75.78% in 2022, then surged 301.15% in 2023.
• Over 5 years, Change in Acquisitions & Divestments stood at $70.0 million in 2022, then surged by 80.63% to $126.5 million in 2023, then slumped by 47.04% to $67.0 million in 2024, then slumped by 41.62% to $39.1 million in 2025, then increased by 24.77% to $48.8 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $48.8 million, $39.1 million, and $50.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.